CBSA creates
co-opportunity
for the Colorado
life sciences
community.

Exchange COVID-19 information, ideas and resources in our CO Life Sciences Connection Center

Connect with our ecosystem at the Colorado Life Sciences Innovation Forum.

Learn More

Colorado BioScience Institute

Our workforce cultivation activities build knowledge, skills and leadership capabilities.

Learn More

Why Colorado

Our robust economy, collaborative culture, leading academic and research institutions, pro-innovation business climate, and excellent quality of life make Colorado a leading choice to start, scale or relocate a life sciences business.

Learn More

Networking + Events

More
23
Wednesday, Sep 23, 2020
10:00am—12:00pm

Next Event

Medical Device Product Development Essentials—Virtual Workshop

23
Wednesday, Sep 23, 2020
10:00am—12:00pm
This program features industry experts who will provide a comprehensive introduction to some of the topics encountered during the development of medical products. Join us from this three-session track on September 9, 16, and 23, 2020
Learn More
24
Thursday, Sep 24, 2020
10:00—11:00am

Next Event

Dealmakers Roundtable: SPACs!

24
Thursday, Sep 24, 2020
10:00—11:00am
Learn More

Stay up to date with one of the country’s most dynamic life sciences ecosystems. Subscribe to the CBSA newsletter today.

Subscribe

Weekly Policy Update: State Releases Updated Economic and Revenue Forecast

Learn More

Weekly Policy Update: President Moves Forward with Most-Favored-Nation Drug Pricing Policy

Learn More

Colorado Partners with Google and Apple to Launch Contact Tracing App

Learn More

Weekly Policy Update: CMS Issues Proposed Rule to Improve Coverage for Breakthrough Technologies

Learn More

Weekly Policy Update: CBSA Member PharmaJet Hosts Visit with Senator Cory Gardner

Learn More

Ampio Reports Positive Results in Early Trial for IV Ampion treatment in COVID-19 Patients

Learn More

Proov Lands VC Funds as Demand Surges for its At Home Test Kits

Learn More

Maker of Mask Designed to treat Chronic Pain Raises 5.8M

Learn More

AnGes and Brickell Biotech Announce a Collaboration Agreement for the Development of a Novel DNA Vaccine Candidate for COVID-19 in the U.S.

Learn More

AveXis renamed Novartis Gene Therapies, signifying the growing importance of gene therapy to Novartis corporate strategy

Learn More

Weekly Policy Update: State Releases Updated Economic and Revenue Forecast

Learn More